Ocuvite
RxNorm concept 218860, brand name (bn).
- RxCUI
- 218860
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/218860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- dl-alpha tocopheryl acetate (PIN, has precise ingredient)
- ascorbic acid 200 MG / beta carotene 1000 UNT / cuprous oxide 2 MG / dl-alpha tocopheryl acetate 60 UNT / lutein 2 MG / sodium selenate 0.055 MG / zinc oxide 40 MG [Ocuvite] (SBDC, ingredient of)
- ascorbic acid / beta carotene / cuprous oxide / lutein / sodium selenate / vitamin E / zinc oxide Oral Tablet [Ocuvite] (SBDF, ingredient of)
- ascorbic acid 200 MG / beta carotene 1000 UNT / cuprous oxide 2 MG / dl-alpha tocopheryl acetate 60 UNT / lutein 2 MG / sodium selenate 0.055 MG / zinc oxide 40 MG Oral Tablet [Ocuvite] (SBD, ingredient of)
- Ocuvite Oral Product (SBDG, ingredient of)
- Ocuvite Pill (SBDG, ingredient of)
- ascorbic acid (IN, tradename of)
- vitamin E (IN, tradename of)
- lutein (IN, tradename of)
- zinc oxide (IN, tradename of)
- beta carotene (IN, tradename of)
- cuprous oxide (IN, tradename of)
- sodium selenate (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 218860 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/218860 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 218860. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.